Bottle
Latest Novartis, AG Patents:
- Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodies
- Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
- CD19 and CD22 chimeric antigen receptors and uses thereof
- Treatment of cancer using GFR alpha-4 chimeric antigen receptor
- Tricyclic AKR1C3 dependent KARS inhibitors
FIG. 1 is a perspective view of a bottle of our new design.
FIG. 2 is a front elevation of the bottle of FIG. 1.
FIG. 3 is a rear elevation of the bottle of FIG. 1.
FIG. 4 is a top plan view of the bottle of FIG. 1.
FIG. 5 is a bottom plan view of the bottle of FIG. 1.
FIG. 6 is a perspective view of a further embodiment of a bottle or our new design.
FIG. 7 is a front elevation of the bottle of FIG. 6.
FIG. 8 is a rear elevation of the bottle of FIG. 6.
FIG. 9 is a top plan view of the bottle of FIG. 6.
FIG. 10 is a bottom plan view of the bottle of FIG. 6.
FIG. 11 is a perspective view of a further embodiment of a bottle or our new design.
FIG. 12 is a front elevation of the bottle of FIG. 11.
FIG. 13 is a rear elevation of the bottle of FIG. 11.
FIG. 14 is a top plan view of the bottle of FIG. 11.
FIG. 15 is a bottom plan view of the bottle of FIG. 11.
FIG. 16 is a perspective view of a further embodiment of a bottle or our new design.
FIG. 17 is a front elevation of the bottle of FIG. 16.
FIG. 18 is a rear elevation of the bottle of FIG. 16.
FIG. 19 is a top plan view of the bottle of FIG. 16; and,
FIG. 20 is a bottom plan view of the bottle of FIG. 16.
The broken line showing of the bottle is included for the purpose of illustrating portions of the bottle and forms no part of the claimed design.
Claims
What is claimed is the ornamental design of a bottle, as shown and described.
D315409 | March 12, 1991 | Baarber |
D353518 | December 20, 1994 | Cautereels et al. |
D412085 | July 20, 1999 | Roush et al. |
D412281 | July 27, 1999 | Lindsay et al. |
D434273 | November 28, 2000 | Johansen et al. |
D445033 | July 17, 2001 | Bretz et al. |
D456714 | May 7, 2002 | Brauner et al. |
D466813 | December 10, 2002 | Thierjung et al. |
D466819 | December 10, 2002 | Darr et al. |
D467179 | December 17, 2002 | Nelson et al. |
6513379 | February 4, 2003 | Meyers et al. |
D475890 | June 17, 2003 | Mazonkey |
D479999 | September 30, 2003 | Moore |
D504063 | April 19, 2005 | Bretz et al. |
D506139 | June 14, 2005 | Zboch et al. |
20020070193 | June 13, 2002 | Mero |
20040155008 | August 12, 2004 | Lane et al. |
20040200799 | October 14, 2004 | Yourist et al. |
20060157439 | July 20, 2006 | Howell |
000403969-0001 | December 2005 | EM |
000403969-0003 | December 2005 | EM |
2084672 | April 1999 | GB |
Type: Grant
Filed: Feb 24, 2005
Date of Patent: Mar 20, 2007
Assignee: Novartis, AG (Basel)
Inventors: John Wolf (Spring Lake, MI), Dean Lindsay (Wilmette, IL), Joey Suntken (Morristown, NJ), Eric Ungrady (Mt. Wolf, PA), Justin Howell (New Cumberland, PA), Philip Sheets (York, PA), Takao Iizuka (Tokyo), Masaaki Sasaki (Tokyo)
Primary Examiner: Stella Reid
Assistant Examiner: Keli L. Acker
Attorney: Mekalaradha Masilamani
Application Number: 29/224,092